Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
SARS-CoV-2 has spread globally. Here, the authors characterize the entry pathway of SARS-CoV-2, show that the SARS-CoV-2 spike protein is less stable than that of SARS-CoV, and show limited cross-neutralization activities between SARS-CoV and SARS-CoV-2 sera.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92d70903056e4689b4f7c4fd01947293 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:92d70903056e4689b4f7c4fd01947293 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:92d70903056e4689b4f7c4fd019472932021-12-02T17:31:09ZCharacterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV10.1038/s41467-020-15562-92041-1723https://doaj.org/article/92d70903056e4689b4f7c4fd019472932020-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15562-9https://doaj.org/toc/2041-1723SARS-CoV-2 has spread globally. Here, the authors characterize the entry pathway of SARS-CoV-2, show that the SARS-CoV-2 spike protein is less stable than that of SARS-CoV, and show limited cross-neutralization activities between SARS-CoV and SARS-CoV-2 sera.Xiuyuan OuYan LiuXiaobo LeiPei LiDan MiLili RenLi GuoRuixuan GuoTing ChenJiaxin HuZichun XiangZhixia MuXing ChenJieyong ChenKeping HuQi JinJianwei WangZhaohui QianNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-12 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Xiuyuan Ou Yan Liu Xiaobo Lei Pei Li Dan Mi Lili Ren Li Guo Ruixuan Guo Ting Chen Jiaxin Hu Zichun Xiang Zhixia Mu Xing Chen Jieyong Chen Keping Hu Qi Jin Jianwei Wang Zhaohui Qian Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
description |
SARS-CoV-2 has spread globally. Here, the authors characterize the entry pathway of SARS-CoV-2, show that the SARS-CoV-2 spike protein is less stable than that of SARS-CoV, and show limited cross-neutralization activities between SARS-CoV and SARS-CoV-2 sera. |
format |
article |
author |
Xiuyuan Ou Yan Liu Xiaobo Lei Pei Li Dan Mi Lili Ren Li Guo Ruixuan Guo Ting Chen Jiaxin Hu Zichun Xiang Zhixia Mu Xing Chen Jieyong Chen Keping Hu Qi Jin Jianwei Wang Zhaohui Qian |
author_facet |
Xiuyuan Ou Yan Liu Xiaobo Lei Pei Li Dan Mi Lili Ren Li Guo Ruixuan Guo Ting Chen Jiaxin Hu Zichun Xiang Zhixia Mu Xing Chen Jieyong Chen Keping Hu Qi Jin Jianwei Wang Zhaohui Qian |
author_sort |
Xiuyuan Ou |
title |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
title_short |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
title_full |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
title_fullStr |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
title_full_unstemmed |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
title_sort |
characterization of spike glycoprotein of sars-cov-2 on virus entry and its immune cross-reactivity with sars-cov |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/92d70903056e4689b4f7c4fd01947293 |
work_keys_str_mv |
AT xiuyuanou characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT yanliu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT xiaobolei characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT peili characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT danmi characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT liliren characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT liguo characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT ruixuanguo characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT tingchen characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT jiaxinhu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT zichunxiang characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT zhixiamu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT xingchen characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT jieyongchen characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT kepinghu characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT qijin characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT jianweiwang characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov AT zhaohuiqian characterizationofspikeglycoproteinofsarscov2onvirusentryanditsimmunecrossreactivitywithsarscov |
_version_ |
1718380685899595776 |